EUVIMEDOpdag EUVIMED
Crossref

Systemic treatment of EGFR-mutated non-small cell lung cancer

Rafał Ł. Czyżykowski, Ewa K. Wrona, Agata Tałajko, Aleksandra M. Hasińska, Piotr J. Potemski

Oncology in Clinical Practice · 2025

DOI: 10.5603/ocp.100697 ↗

At a glance

Journal article in Oncology in Clinical Practice, 2025. Written by Rafał Ł. Czyżykowski and 4 co-authors.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a significant global health challenge, re­sponsible for a substantial portion of cancer-related deaths. This review focuses on the pivotal role of epidermal growth factor receptor gene (EGFR) mutations in NSCLC, exploring their prevalence, diagnostic methods, and im­plications for targeted therapy. Common mutations in EGFR, constituting approximately 90% of all mutations, are associated with better prognosis and predict favourable response to EGFR tyrosine kinase inhibitors. Meanwhile, the remaining 10–15% comprise atypical mutations, including uncommon exon 18 mutations, exon 20 insertions, de novo T790M mutations, compound mutations, and others. The frequency of uncommon mutations has recently increased, posing challenges due to their largely unknown biological and clinical implications. The review under­scores the necessity of summarizing recent scientific discoveries in EGFR mutations to enhance our understanding of their diverse nature and optimize targeted therapeutic approaches in NSCLC patients.

Cite

APA

Czyżykowski, R. Ł., Wrona, E. K., Tałajko, A., Hasińska, A. M., & Potemski, P. J. (2025). Systemic treatment of EGFR-mutated non-small cell lung cancer. Oncology in Clinical Practice. https://doi.org/10.5603/ocp.100697

Vancouver

Czyżykowski RŁ, Wrona EK, Tałajko A, Hasińska AM, Potemski PJ. Systemic treatment of EGFR-mutated non-small cell lung cancer. Oncology in Clinical Practice. 2025. doi:10.5603/ocp.100697

BibTeX
@article{Czyykowski2025,
  author = {Czyżykowski, Rafał Ł. and Wrona, Ewa K. and Tałajko, Agata and Hasińska, Aleksandra M. and Potemski, Piotr J.},
  title = {Systemic treatment of EGFR-mutated non-small cell lung cancer},
  journal = {Oncology in Clinical Practice},
  year = {2025},
  doi = {10.5603/ocp.100697}
}
Start for free →